Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Enfusion's Return on Invested Capital Insights

According to data from Benzinga Pro, during Q1, Enfusion's (NYSE:ENFN) reported sales totaled $34.14 million. Despite a 95.74% increase in earnings, the company posted a loss of $12.52 million. In Q4, Enfusion brought in $31.85 million in sales but lost $293.89 million in earnings.

Why Is ROIC Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.